Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
โ Scribed by T. Livraghi; S. Lazzaroni; F. Meloni; L. Solbiati
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 76 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.4986
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background
A recent small study reported a high rate of neoplastic seeding after cooled-tip radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) in patients who had undergone previous needle biopsy. Tumour seeding was associated with subcapsular tumour location, poorly differentiated tumours and a high ฮฑ-fetoprotein (AFP) level. The aim of the present study was to determine the rate of neoplastic seeding after RFA in a large series of unselected patients with HCC who had a long follow-up.
Methods
A total of 1314 patients with 2542 nodules were treated in three centres. Median follow-up was 37 months. Needle biopsy had been performed before RFA in 241 patients (18ยท3 per cent). The influence of subcapsular location, high AFP level and previous biopsy on risk of tumour seeding was assessed.
Results
Neoplastic seeding was identified in 12 patients (0ยท9 per cent); the rate was comparable at the three centres (0ยท9, 0ยท7 and 1ยท4 per cent). Only previous biopsy was significantly associated with tumour seeding (P = 0ยท004).
Conclusion
RFA with a cooled-tip needle was associated with a low risk of neoplastic seeding, even in unselected patients. The use of biopsy before RFA is to be discouraged, particularly when liver transplantation is a possibility at a later date.
๐ SIMILAR VOLUMES
## BACKGROUND. Radiofrequency ablation (RFA) for patients with hepatocellular carcinoma (HCC) has been reported previously. This technique is superior to percutaneous microwave coagulation therapy (PMCT) for the enlargement of the necrotic area. Therefore, a few treatment sessions of RFA for patie
## Abstract ## Background Despite being one of the commonest causes of cancer-related death around the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative treatment (surgical resection or liver transplantation). Radiofrequency ablation (RFA) has emerged as a popula
## Abstract ## Background The role of radiofrequency ablation (RFA) for perivascular (up to 5 mm from the major intrahepatic portal vein or hepatic vein branches) hepatocellular carcinoma (HCC) is unclear because of possible incomplete tumour ablation and potential vascular damage. This study aime